Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →

Clinical Trials Directory

Browse and search research studies sourced from ClinicalTrials.gov and our partner researchers.

17,425 studies found

Active Not Recruiting
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malign...

Conditions: Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma

Children's Hospital of Alabama Birmingham Alabama

View details
Recruiting
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Conditions: Carcinoma, Hepatocellular, Cirrhosis

Birmingham VA Medical Center, Birmingham, AL Birmingham...

View details
Recruiting
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S...

Conditions: Cervical Carcinoma, Human Papillomavirus Infection

University of Alabama at Birmingham Cancer Center Birmi...

View details
Active Not Recruiting
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocyt...

Conditions: Advanced Malignant Solid Neoplasm, Recurrent Ependymal Tumor, Recurrent Ewing Sa...

Children's Hospital of Alabama Birmingham Alabama

View details
Active Not Recruiting
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemor...

Conditions: Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II L...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Active Not Recruiting
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That...

Conditions: Lung Non-Squamous Non-Small Cell Carcinoma, Stage IB Lung Non-Small Cell Carcino...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Recruiting
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

Conditions: Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

Excel ENT Birmingham Alabama

View details
Recruiting
ASSESS ALL ALS Study

Conditions: Amyotrophic Lateral Sclerosis

University of Alabama Birmingham Birmingham Alabama

View details
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Ele...

Conditions: Atherosclerotic Cardiovascular Disease (ASCVD)

Parkway Medical Center Birmingham Alabama

View details
Active Not Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Re...

Conditions: Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann...

Children's Hospital of Alabama Birmingham Alabama

View details
Active Not Recruiting
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromato...

Conditions: Low Grade Glioma, Neurofibromatosis Type 1, Visual Pathway Glioma

Children's Hospital of Alabama Birmingham Alabama

View details
Not Yet Recruiting
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Re...

Conditions: Obesity, Overweight, or Chronic Weight Management

ACCOMPLISH-1 Research Site Birmingham Alabama

View details
Active Not Recruiting
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Dia...

Conditions: B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome

Children's Hospital of Alabama Birmingham Alabama

View details
Active Not Recruiting
Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas

Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Ce...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Not Yet Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

Conditions: Idiopathic Pulmonary Fibrosis (IPF)

Research Site Birmingham Alabama

View details
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Gli...

Conditions: Low Grade Astrocytoma, Low Grade Glioma, Metastatic Low Grade Astrocytoma, Metas...

Children's Hospital of Alabama Birmingham Alabama

View details
Active Not Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment...

Conditions: Endometrial Endometrioid Adenocarcinoma, Stage I Uterine Corpus Carcinoma or Car...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Active Not Recruiting
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Recurrent Cervical Ca...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Recruiting
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Tr...

Conditions: Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent O...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Active Not Recruiting
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell...

Conditions: Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Can...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Active Not Recruiting
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Ana...

Conditions: Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Margin Squamous...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Recruiting
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

Conditions: Bronchopulmonary Dysplasia, Pulmonary Hypertension

The University of Alabama at Birmingham Birmingham Alab...

View details
Recruiting
PREVENT ALL ALS Study

Conditions: Amyotrophic Lateral Sclerosis

University of Alabama Birmingham Birmingham Alabama

View details
Recruiting
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

Conditions: Human Papillomavirus-Related Carcinoma

University of Alabama at Birmingham Cancer Center Birmi...

View details